$POLA
Polar Power, Inc. Stock $pola

$pola Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000149315223010248 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$4.190M	$6.366M	$16.06M
YoY Change	12.97%	37.7%	-4.97%
Cost Of Revenue	$3.435M	$5.960M	$13.93M
YoY Change	22.5%	95.22%	3.57%
Gross Profit	$755.0K	$406.0K	$2.125M
YoY Change	-16.57%	-74.14%	-38.32%
Gross Profit Margin	18.02%	6.38%	13.23%
Selling, General & Admin	$1.444M	$1.465M	$6.198M
YoY Change	-5.99%	128.19%	36.01%
% of Gross Profit	191.26%	360.84%	291.67%
Research & Development	$346.0K	$315.0K	$1.460M
YoY Change	-27.31%	-37.13%	-26.49%
% of Gross Profit	45.83%	77.59%	68.71%
Depreciation & Amortization	$116.0K	$120.0K	$507.0K
YoY Change	-14.07%	-6.98%	-7.65%
% of Gross Profit	15.36%	29.56%	23.86%
Operating Expenses	$1.790M	$1.731M	$7.658M
YoY Change	-11.03%	51.44%	17.04%
Operating Profit	-$1.035M	-$1.325M	-$5.533M
YoY Change	-6.5%	-410.3%	78.6%
Interest Expense	$78.00K	-$19.00K	$58.00K
YoY Change	-700.0%	35.71%	-196.67%
% of Operating Profit
Other Income/Expense, Net	-$78.00K	$0.00	-$51.00K
YoY Change			-275.86%
Pretax Income	-$1.113M	-$1.344M	-$5.584M
YoY Change	-0.63%	-425.42%	294.91%
Income Tax
% Of Pretax Income
Net Earnings	-$1.113M	-$1.344M	-$5.584M
YoY Change	-0.63%	-425.42%	294.91%
Net Earnings / Revenue	-26.56%	-21.11%	-34.78%
Basic Earnings Per Share	-$0.09		-$0.43
Diluted Earnings Per Share	-$0.09	-$0.11	-$0.43
COMMON SHARES
Basic Shares Outstanding	12.95M shares	12.95M shares	12.88M shares
Diluted Shares Outstanding	12.95M shares		12.88M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$119.0K	$211.0K	$211.0K
YoY Change	-97.16%	-95.86%	-95.86%
Cash & Equivalents	$119.0K	$211.0K	$211.0K
Short-Term Investments
Other Short-Term Assets	$3.852M	$4.629M	$4.629M
YoY Change	-26.82%	-22.93%	-22.93%
Inventory	$16.88M	$15.46M	$15.46M
Prepaid Expenses	$1.852M	$2.629M
Receivables	$3.216M	$2.230M	$2.230M
Other Receivables	$787.0K	$787.0K	$787.0K
Total Short-Term Assets	$24.85M	$23.32M	$23.32M
YoY Change	2.1%	-7.3%	-7.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$421.0K	$538.0K	$778.0K
YoY Change	-74.34%	-47.2%	-59.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$93.00K	$93.00K	$93.00K
YoY Change	0.0%	0.0%	0.0%
Total Long-Term Assets	$2.950M	$871.0K	$871.0K
YoY Change	70.13%	-57.01%	-57.01%
TOTAL ASSETS
Total Short-Term Assets	$24.85M	$23.32M	$23.32M
Total Long-Term Assets	$2.950M	$871.0K	$871.0K
Total Assets	$27.80M	$24.19M	$24.19M
YoY Change	6.62%	-11.01%	-11.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.024M	$230.0K	$230.0K
YoY Change	88.24%	-29.88%	-29.88%
Accrued Expenses	$1.994M	$1.499M	$1.499M
YoY Change	4.84%	-22.21%	-22.21%
Deferred Revenue
YoY Change
Short-Term Debt	$3.010M	$1.884M	$1.884M
YoY Change
Long-Term Debt Due	$172.0K	$211.0K	$211.0K
YoY Change	-29.8%	-12.81%	-12.81%
Total Short-Term Liabilities	$8.969M	$5.950M	$5.950M
YoY Change	148.17%	75.31%	75.31%
LONG-TERM LIABILITIES
Long-Term Debt	$33.00K	$57.00K	$57.00K
YoY Change	-83.9%	-78.73%	-78.73%
Other Long-Term Liabilities	$1.729M	$0.00	$0.00
YoY Change	1305.69%	-100.0%	-100.0%
Total Long-Term Liabilities	$1.762M	$57.00K	$57.00K
YoY Change	437.2%	-89.37%	-89.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.969M	$5.950M	$5.950M
Total Long-Term Liabilities	$1.762M	$57.00K	$57.00K
Total Liabilities	$10.73M	$6.007M	$6.007M
YoY Change	172.22%	52.85%	52.85%
SHAREHOLDERS EQUITY
Retained Earnings	-$20.22M	-$19.11M
YoY Change		41.28%
Common Stock	$1.000K	$1.000K
YoY Change		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$40.00K
YoY Change		0.0%
Treasury Stock Shares		17.48K shares
Shareholders Equity	$17.07M	$18.18M	$18.18M
YoY Change
Total Liabilities & Shareholders Equity	$27.80M	$24.19M	$24.19M
YoY Change	6.62%	-11.01%	-11.01%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$1.113M	-$1.344M	-$5.584M
YoY Change	-0.63%	-425.42%	294.91%
Depreciation, Depletion And Amortization	$116.0K	$120.0K	$507.0K
YoY Change	-14.07%	-6.98%	-7.65%
Cash From Operating Activities	-$1.156M	-$1.975M	-$6.507M
YoY Change	36.48%	-20.68%	-30.63%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$25.00K
YoY Change		-100.0%	-135.21%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		$0.00	-$25.00K
YoY Change		-100.0%	-64.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.064M	1.823M	$1.642M
YoY Change	-1873.33%	-3243.1%	-87.28%
NET CHANGE
Cash From Operating Activities	-$1.156M	-1.975M	-$6.507M
Cash From Investing Activities		0.000	-$25.00K
Cash From Financing Activities	$1.064M	1.823M	$1.642M
Net Change In Cash	-$92.00K	-152.0K	-$4.890M
YoY Change	-89.95%	-94.17%	-241.53%
FREE CASH FLOW
Cash From Operating Activities	-$1.156M	-$1.975M	-$6.507M
Capital Expenditures		$0.00	$25.00K
Free Cash Flow	-$1.156M	-$1.975M	-$6.532M
YoY Change	37.78%	-18.82%	-29.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001622345
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	POLA	Gain On Forgiveness Of Loan Payable GainOnForgivenessOfLoanPayable		usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022	POLA	Gain On Forgiveness Of Loan Payable GainOnForgivenessOfLoanPayable		usd
CY2022	POLA	Increase Decrease In Employee Retention Credit Receivable IncreaseDecreaseInEmployeeRetentionCreditReceivable		usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable		usd
CY2022	POLA	Proceeds From Sale Of Common Stock Net Of Offering Costs ProceedsFromSaleOfCommonStockNetOfOfferingCosts		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2021	POLA	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2022	POLA	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2022	POLA	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	POLA	Carryback Net Operating Loss CarrybackNetOperatingLoss		pure
CY2021	POLA	Carryback Net Operating Loss CarrybackNetOperatingLoss		pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-37960
CY2022	dei	Entity Registrant Name EntityRegistrantName	Polar Power, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-0479020
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	249 E. Gardena Blvd.
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Gardena
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90248
CY2022	dei	City Area Code CityAreaCode	(310)
CY2022	dei	Local Phone Number LocalPhoneNumber	830-9153
CY2022	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value
CY2022	dei	Trading Symbol TradingSymbol	POLA
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	19125724	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12949550	shares
CY2022	dei	Auditor Firm AuditorFirmId	572
CY2022	dei	Auditor Name AuditorName	Weinberg & Company, P.A
CY2022	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	211000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5101000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2230000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4243000	usd
CY2022Q4	POLA	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	2000000	usd
CY2021Q4	POLA	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	2000000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	15460000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	9017000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2629000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4006000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	787000	usd
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	787000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	23317000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	25154000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	240000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	914000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	538000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1019000	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	93000	usd
CY2021Q4	us-gaap	Deposit Assets DepositAssets	93000	usd
CY2022Q4	us-gaap	Assets Assets	24188000	usd
CY2021Q4	us-gaap	Assets Assets	27180000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	230000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	328000	usd
CY2022Q4	us-gaap	Deposits Deposits	2126000	usd
CY2021Q4	us-gaap	Deposits Deposits	897000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1231000	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1206000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	268000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	721000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	211000	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	242000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1884000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5950000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3394000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	57000	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	268000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	268000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6007000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3930000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12967027	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12949550	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12805680	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12788203	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	37331000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	36816000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19111000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13527000	usd
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	17477	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	17477	shares
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	40000	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	40000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	18181000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23250000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24188000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27180000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16056000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16896000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	13931000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	13451000	usd
CY2022	us-gaap	Gross Profit GrossProfit	2125000	usd
CY2021	us-gaap	Gross Profit GrossProfit	3445000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1471000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1488000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1460000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1986000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4727000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3069000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	7658000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	6543000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5533000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-3098000	usd
CY2022	us-gaap	Interest Expense InterestExpense	58000	usd
CY2021	us-gaap	Interest Expense InterestExpense	60000	usd
CY2021	POLA	Gain On Forgiveness Of Loan Payable GainOnForgivenessOfLoanPayable	1715000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	29000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-51000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1684000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5584000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1414000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12878350	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12720499	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11491000	usd
CY2021	POLA	Stock Issued During Period Value Shares Of Common Stock Issued With Warrants For Cash StockIssuedDuringPeriodValueSharesOfCommonStockIssuedWithWarrantsForCash	12466000	usd
CY2021	POLA	Stock Issued During Period Values Common Stock Issued Upon Exercise Of Warrants StockIssuedDuringPeriodValuesCommonStockIssuedUponExerciseOfWarrants	707000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1414000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23250000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23250000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	515000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5584000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	18181000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	18181000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5584000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1414000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	507000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	549000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	515000	usd
CY2021	POLA	Gain On Forgiveness Of Loan Payable GainOnForgivenessOfLoanPayable	1715000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2013000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3052000	usd
CY2021	POLA	Increase Decrease In Employee Retention Credit Receivable IncreaseDecreaseInEmployeeRetentionCreditReceivable	2000000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6443000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-77000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-1377000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	3648000	usd
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-1570000	usd
CY2022	POLA	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-674000	usd
CY2021	POLA	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-649000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-98000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	16000	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	1229000	usd
CY2021	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	194000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	25000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	65000	usd
CY2022	POLA	Increase Decrease In Lease Liability IncreaseDecreaseInLeaseLiability	-722000	usd
CY2021	POLA	Increase Decrease In Lease Liability IncreaseDecreaseInLeaseLiability	-671000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6507000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9380000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	71000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-25000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-71000	usd
CY2021	POLA	Proceeds From Sale Of Common Stock Net Of Offering Costs ProceedsFromSaleOfCommonStockNetOfOfferingCosts	12466000	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	707000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	242000	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	267000	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1884000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1642000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12906000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4890000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3455000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5101000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1646000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	211000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5101000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5584000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6507000	usd
CY2022Q4	us-gaap	Cash Cash	211000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	1137000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	18181000	usd
CY2022Q4	POLA	Working Capital WorkingCapital	17367	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_z7E7X6f0jf69" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zc5wroLFyz26">Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Material estimates relate to the assumptions made in determining reserves for uncollectible receivables, inventory net realizable value, impairment analysis of long-term assets, valuation allowance on deferred tax assets, accruals for potential liabilities and warrant reserves, assumptions made in valuing equity instruments issued for services, and assumptions used in the determination of the Company’s liquidity. Actual results may differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16056000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16896000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16056000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16896000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16056000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16896000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2020Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2022	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	508000	usd
CY2021	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	658000	usd
CY2022	POLA	Standard Product Warranty Accrual Provision StandardProductWarrantyAccrualProvision	508000	usd
CY2021	POLA	Standard Product Warranty Accrual Provision StandardProductWarrantyAccrualProvision	658000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	600000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	268000	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	510000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	211000	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	242000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	57000	usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	268000	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	510000	usd
CY2022	POLA	Payments For Notes Payable PaymentsForNotesPayable	242000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	268000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	12277000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	6607000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3183000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2410000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	15460000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	9017000	usd
CY2021	us-gaap	Depreciation Depreciation	530000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1460000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1986000	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	164122	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	164122	shares
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_zisSyldpC1Ql" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zbZJRS7AFO3i">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenues</i>. For the year ended December 31, 2022, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zgDsYUTt0kfh" title="Concentration risk">66</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zLvAUPRlbHFi" title="Concentration risk">23</span>%, respectively, of our revenue was generated from the Company’s two largest customers, one being a Tier-1 telecommunications customer in the U.S. and one being a telecommunications customer outside the U.S. In 2021, <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zeHfopAHPQQ6" title="Concentration risk">67</span>% of revenue was generated from the Company’s largest customer, a Tier-1 telecommunications customer in the U.S. In 2022 and 2021, sales to telecommunications customers accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zZxLBSGeWWD1" title="Concentration risk">96</span>% and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zQk39c6Zil8f" title="Concentration risk">89</span>% of total revenue, respectively. In 2022 and 2021, sales to international customers accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zl7L3nbs3SAd" title="Concentration risk">25</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_z9ic7GMZ2CK7" title="Concentration risk">8</span>% of total revenue, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable</i>. At December 31, 2022, the Company’s largest receivable account represented <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zLnY6Dnuq92i" title="Concentration risk">90</span>% of the Company’s total accounts receivable. At December 31, 2021, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zIVbSDnA1Slk" title="Concentration risk">74</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zMhZRsM3TgEa" title="Concentration risk">15</span>% of the Company’s accounts receivable was from the Company’s two largest receivable accounts. There was no other customer that accounted for more than 10% of the Company’s accounts receivable as of the years ended December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts payable</i>. On December 31, 2022, the three largest accounts payable accounts to the Company’s vendors represented <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestVendorsOnesMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zL7rKbVmtWQg" title="Concentration risk">51</span>%, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zXNA8pIpW0T" title="Concentration risk">3</span>%, and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestCustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zc5sCqbJeM3j" title="Concentration risk">3</span>%, respectively. On December 31, 2021, the three largest accounts payable accounts to the Company’s largest vendors represented <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--LargestVendorsOnesMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zbd3Psubu4Md" title="Concentration risk">16</span>%, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zcjQLmBUkMfk" title="Concentration risk">9</span>%, and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--LargestCustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zZ682RuWGCn6" title="Concentration risk">9</span>%, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4300000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4278000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3762000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3259000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	538000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1019000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	507000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	549000	usd
CY2022	us-gaap	Depreciation Depreciation	489000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	211000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	57000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	268000	usd
CY2021	POLA	Gain On Forgiveness Of Loan Payable GainOnForgivenessOfLoanPayable	1715000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	699000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	699000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	699000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	699000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y4M24D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y4M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0375	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0375	pure
CY2022Q4	POLA	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	2577000	usd
CY2021Q4	POLA	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	1903000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	240000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	914000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	268000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	721000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	268000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	268000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	989000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	280000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	280000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	12000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	268000	usd
CY2022	us-gaap	Payments For Rent PaymentsForRent	975000	usd
CY2021	us-gaap	Payments For Rent PaymentsForRent	903000	usd
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	17477	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	17477	shares
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	40000	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	40000	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	140000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.22
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	140000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.22
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	140000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.22
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	140000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	140000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	370000	shares
CY2020Q4	POLA	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	8.75
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	345878	shares
CY2021	POLA	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice	4.07
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	24122	shares
CY2021Q4	POLA	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	3.13
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	24122	shares
CY2022Q4	POLA	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	3.13
CY2022Q4	POLA	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber	24122	shares
CY2022Q4	POLA	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice	3.13
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.07	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.07	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.28	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.28	pure
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1462000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1373000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	254000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	257000	usd
CY2022Q4	POLA	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	75000	usd
CY2021Q4	POLA	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	277000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3262000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3158000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5053000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5065000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4863000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4701000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	190000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	364000	usd
CY2022Q4	POLA	Deferred Tax Liability Operating Lease Rightofuse Asset Net DeferredTaxLiabilityOperatingLeaseRightofuseAssetNet	67000	usd
CY2021Q4	POLA	Deferred Tax Liability Operating Lease Rightofuse Asset Net DeferredTaxLiabilityOperatingLeaseRightofuseAssetNet	128000	usd
CY2022Q4	POLA	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	123000	usd
CY2021Q4	POLA	Deferred Tax Liabilities Depreciation DeferredTaxLiabilitiesDepreciation	236000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	190000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	364000	usd
CY2021	us-gaap	Tax Credit Carryforward Description TaxCreditCarryforwardDescription	the TCJA limits NOL absorption to 80% of taxable income. At December 31, 2022 and 2021, the Company had income taxes receivable of $787 related to the NOL carrybacks.
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	787000	usd
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	787000	usd
CY2022Q4	POLA	Offset Of Taxable Income Percentage OffsetOfTaxableIncomePercentage	0.80	pure
CY2021	POLA	Employee Retention Credits Wages Percentage EmployeeRetentionCreditsWagesPercentage	0.70	pure
CY2021	POLA	Employee Retention Credits Per Shares EmployeeRetentionCreditsPerShares	7
CY2021Q4	POLA	Expenses Of Employee Retention Credit ExpensesOfEmployeeRetentionCredit	2000000	usd
CY2021	POLA	Employee Retention Credits Cost Of Sales EmployeeRetentionCreditsCostOfSales	1300000	usd
CY2021	POLA	Employee Retention Credits Operating Expenses EmployeeRetentionCreditsOperatingExpenses	700000	usd
CY2022Q4	POLA	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	2000000	usd
CY2021Q4	POLA	Employee Retention Credit Receivable EmployeeRetentionCreditReceivable	2000000	usd

Files In Submission

Name	View Source	Status
pola-20221231_def.xml	Edgar Link	unprocessable
0001493152-23-010248-index-headers.html	Edgar Link	pending
0001493152-23-010248-index.html	Edgar Link	pending
0001493152-23-010248.txt	Edgar Link	pending
0001493152-23-010248-xbrl.zip	Edgar Link	pending
ex10-10.htm	Edgar Link	pending
ex10-9.htm	Edgar Link	pending
ex10-9_001.jpg	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex4-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pola-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pola-20221231_cal.xml	Edgar Link	unprocessable
pola-20221231_lab.xml	Edgar Link	unprocessable
pola-20221231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$POLA
Polar Power, Inc. Stock $pola

2023 Q1 Form 10-K Financial Statement

#000149315223010248 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POLA Polar Power, Inc. Stock $pola

2023 Q1 Form 10-K Financial Statement

#000149315223010248 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$POLA
Polar Power, Inc. Stock $pola